Loading...
Skip to main content
The Impact Investor LogoThe Impact Investor Logo
Search for stocks by symbol or company name. Use arrow keys to navigate suggestions.
AI Assistant
The Impact Investor Logo

Empowering retail investors to invest responsibly for their future while making a positive social impact.

Quick Links

  • Blog
  • ESG Stocks
  • Marketplace
  • Sectors
  • About Us

Newsletter

Join our newsletter to get updates on impact investing opportunities.

Privacy policy acceptance is required to subscribe

© 2025 The Impact Investor. All rights reserved.

Privacy Policy | Disclaimer
  1. Home
  2. Industries
23 Best Pharmaceuticals Industry Stocks to Invest in Today | ESG Analysis | The Impact Investor
  1. Home
  2. Industries
  3. Pharmaceuticals

Best Pharmaceuticals Industry Stocks to Invest in Today

Discover the top-performing companies in the pharmaceuticals industry that combine strong returns with positive social impact. Explore 23 carefully selected stocks with real-time data and ESG ratings.

Data updated in real-time • 23 stocks analyzed • ESG ratings included

Pharmaceuticals Industry Analysis

Pharmaceutical companies researching, developing, and manufacturing medicines with emphasis on global health access and ethical pricing.

Industry Statistics

Companies Analyzed23
Total Market Companies16
Avg. Market Cap$3.4T

Growth Drivers

Aging population demographics, emerging disease challenges, personalized medicine advancement, biotechnology innovation, global market expansion, and preventive healthcare focus.

Industry Overview

Pharmaceutical industry includes companies discovering, developing, manufacturing, and marketing medicines and vaccines to treat diseases and improve human health globally with focus on accessibility, safety, and ethical practices.

Key Characteristics

Long development timelines, high R&D investments, regulatory compliance requirements, patent-protected products, global distribution networks, and clinical trial expertise.

ESG Considerations

Drug pricing transparency, global health access initiatives, clinical trial diversity, patient safety prioritization, ethical research practices, environmental impact reduction, and community health programs.

Regulatory Environment

FDA approval processes, international drug regulations, clinical trial oversight, manufacturing quality standards, patent protection laws, and pricing transparency requirements.

Top Pharmaceuticals Industry Stock Picks Today

Interactive table showing the best-performing stocks with ESG ratings and key financial metrics

Showing 1 to 20 of 23 stocks

Page 1 of 2

Company
Price
Votes
Market Cap
ESG RatingAction
AstraZeneca
A5
$76.50
0
$19.6B86/100View Details →
Bausch Health Companies Inc.
BHC
$419.73
0
$17.4BN/AView Details →
Bayer
B10
$18.50
0
$74.1M26/100View Details →
Bristol-Myers Squibb Company
BMY
$117.20
0
$3.6B66/100View Details →
Catalent, Inc.
CTLT
$210.55
0
$3.2B72.7/100View Details →
EMD Group
E4
$174.31
0
$6.1B94/100View Details →
Elanco Animal Health Incorporated
ELAN
$274.19
0
$5.6BN/AView Details →
Eli Lilly and Company
LLY
$140.54
0
$2.6B80/100View Details →
GlaxoSmithKline
G1
$486.02
0
$14.3B81/100View Details →
Johnson & Johnson
JNJ
$333.61
0
$3.0B65/100View Details →
Lannett Company, Inc.
LCI
$20.78
0
$778.1MN/AView Details →
Merck & Co. Inc.
MRK
$282.59
0
$6.2B70/100View Details →
Novartis
N
$270.63
0
$4.6B82/100View Details →
Novo Nordisk
NN
$172.20
0
$261.6M88/100View Details →
Nuvation Bio Inc.
NUVB
$81.57
0
$1.1BN/AView Details →
Organon & Co.
OGN
$504.25
0
$12.6BN/AView Details →
Perrigo Company plc
PRGO
$281.69
0
$13.7BN/AView Details →
Pfizer Inc.
PFE
$117.97
0
$4.0B80/100View Details →
Prestige Consumer Healthcare Inc.
PBH
$280.49
0
$9.4BN/AView Details →
Sanofi
S2
$357.16
0
$16.1B84/100View Details →
AstraZeneca
A5
ESG: 86/100
Price:$76.50
Votes:0
Market Cap:$19.6B
View Complete Analysis
Bausch Health Companies Inc.
BHC
Price:$419.73
Votes:0
Market Cap:$17.4B
View Complete Analysis
Bayer
B10
ESG: 26/100
Price:$18.50
Votes:0
Market Cap:$74.1M
View Complete Analysis
Bristol-Myers Squibb Company
BMY
ESG: 66/100
Price:$117.20
Votes:0
Market Cap:$3.6B
View Complete Analysis
Catalent, Inc.
CTLT
ESG: 72.7/100
Price:$210.55
Votes:0
Market Cap:$3.2B
View Complete Analysis
EMD Group
E4
ESG: 94/100
Price:$174.31
Votes:0
Market Cap:$6.1B
View Complete Analysis
Elanco Animal Health Incorporated
ELAN
Price:$274.19
Votes:0
Market Cap:$5.6B
View Complete Analysis
Eli Lilly and Company
LLY
ESG: 80/100
Price:$140.54
Votes:0
Market Cap:$2.6B
View Complete Analysis
GlaxoSmithKline
G1
ESG: 81/100
Price:$486.02
Votes:0
Market Cap:$14.3B
View Complete Analysis
Johnson & Johnson
JNJ
ESG: 65/100
Price:$333.61
Votes:0
Market Cap:$3.0B
View Complete Analysis
Lannett Company, Inc.
LCI
Price:$20.78
Votes:0
Market Cap:$778.1M
View Complete Analysis
Merck & Co. Inc.
MRK
ESG: 70/100
Price:$282.59
Votes:0
Market Cap:$6.2B
View Complete Analysis
Novartis
N
ESG: 82/100
Price:$270.63
Votes:0
Market Cap:$4.6B
View Complete Analysis
Novo Nordisk
NN
ESG: 88/100
Price:$172.20
Votes:0
Market Cap:$261.6M
View Complete Analysis
Nuvation Bio Inc.
NUVB
Price:$81.57
Votes:0
Market Cap:$1.1B
View Complete Analysis
Organon & Co.
OGN
Price:$504.25
Votes:0
Market Cap:$12.6B
View Complete Analysis
Perrigo Company plc
PRGO
Price:$281.69
Votes:0
Market Cap:$13.7B
View Complete Analysis
Pfizer Inc.
PFE
ESG: 80/100
Price:$117.97
Votes:0
Market Cap:$4.0B
View Complete Analysis
Prestige Consumer Healthcare Inc.
PBH
Price:$280.49
Votes:0
Market Cap:$9.4B
View Complete Analysis
Sanofi
S2
ESG: 84/100
Price:$357.16
Votes:0
Market Cap:$16.1B
View Complete Analysis
23
Total Stocks
23
With Pricing Data
13
ESG Rated
0
Avg. Votes

Why Invest in Pharmaceuticals Industry Stocks?

Growth Potential

Pharmaceuticals industry showing strong market fundamentals. The pharmaceuticals industry presents compelling opportunities for investors seeking both financial returns and positive impact.

Sustainable Impact

Companies in this industry are focusing on sustainable practices. Companies in this industry are increasingly focusing on environmental stewardship and social responsibility.

Investment Merit

Attractive investment opportunities with ESG alignment. Our analysis of 23 stocks reveals strong fundamentals combined with ESG excellence.

Market Context: The pharmaceuticals industryhas demonstrated resilience and innovation, particularly in adapting to ESG principles. Recent trends show increasing investor interest in sustainable practices within this space, making it an attractive area for impact-conscious investors seeking both returns and positive change.

How to Start Investing in Pharmaceuticals Industry Stocks

A simple 3-step guide to begin your pharmaceuticals industry investment journey

1

Choose a Brokerage

Open an account with a reliable trading platform that offers fractional shares for pharmaceuticals industry stocks.

Commission-free trades
Fractional shares available
Strong research tools
2

Diversify & Allocate

Don't put all funds in one stock. Consider spreading investments across multiple pharmaceuticals companies or related ETFs.

Reduce risk
Multiple opportunities
Balanced exposure
3

Monitor & Learn

Stay informed about market trends, ESG developments, and company performance through our regular updates.

Weekly insights
ESG analysis
Market trends

Investment Tips for Pharmaceuticals Industry Stocks

Start Small

Begin with amounts you're comfortable with. Most brokerages allow investments as low as $1 with fractional shares.

Think Long-Term

ESG investing often rewards patience. Focus on companies with sustainable business models and strong fundamentals.

Stay Informed

Follow earnings reports, ESG initiatives, and industry trends to make informed decisions about your holdings.

Review Regularly

Assess your portfolio quarterly, but avoid daily monitoring which can lead to emotional decision-making.

Important Disclaimer: This content is for educational purposes only and should not be considered personalized investment advice. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results. Please consult with a qualified financial advisor before making investment decisions.

Our Methodology for Selecting the Best Pharmaceuticals Industry Stocks

Transparent, data-driven approach to identifying top-performing ESG stocks

Financial Performance

Revenue growth, profitability, debt-to-equity ratios, and analyst consensus ratings

ESG Excellence

MSCI ESG ratings, Sustainalytics scores, and environmental/social governance practices

Real-Time Data

Live pricing from Alpha Vantage API, updated financial metrics, and market performance

Market Leadership

Industry position, competitive advantages, and innovation in sustainable practices

Data Sources & Transparency

Our analysis combines real-time financial data from Alpha Vantage API, ESG ratings from MSCI and Sustainalytics, and fundamental data stored in our PostgreSQL database.

All stock selections undergo quarterly review to ensure continued alignment with our ESG standards and financial performance criteria. We maintain independence in our analysis and clearly disclose any affiliate relationships.

Disclosure: Some links on this page are affiliate links. We may earn a commission if you sign up for services through these links, but this does not influence our stock selections or recommendations.

Real-Time Updates

Stock prices and key metrics are updated in real-time during market hours. ESG ratings are reviewed monthly to reflect the latest sustainability assessments.

Frequently Asked Questions about Pharmaceuticals Industry Stocks

Common questions from investors interested in pharmaceuticals industry investing

The Pharmaceuticals industry is positioned for continued growth driven by technological innovation, sustainability initiatives, and changing consumer preferences. Industry analysts project strong fundamentals with increasing focus on ESG practices. Companies in this industry are adapting to regulatory changes and market demands for more sustainable business models.

Have more questions? Feel free tocontact our team orsubscribe to our newsletter for regular updates and insights on pharmaceuticals industry investing.

Stay Updated on Pharmaceuticals Industry Investing

Join 5,000+ investors who receive our weekly insights on the best pharmaceuticals industry stocks, market trends, and ESG developments.

Weekly stock picks and market analysis
Exclusive ESG insights and ratings updates
Early access to new investment opportunities

🔒 No spam, unsubscribe anytime. We respect your privacy and never share your email.

5,000+
Subscribers
94%
Open Rate
Weekly
Insights
Free
Forever